Tigerlily Foundation

Triple Negative Breast Cancer (TNBC) is a type of breast cancer that is diagnosed in two U.S. women every hour, adding up to over 17,000 U.S. women per year. TNBC develops in the breast because of the presence of abnormal or cancer cells that look and behave differently from the normal cells in the breast. These proteins are called receptors, and they are usually located on the surface of or inside of cells: estrogen receptor (ER), progesterone receptor (PR) and Learning that you have triple negative breast cancer (TNBC) adds an additional layer of questions about your treatment plan and survivorship.

In 2015, Sarah was diagnosed with Stage 3 Triple Negative Breast Cancer, at 36 years old and 32 weeks pregnant. Our skin is our largest organ, and everything we put onto our bodies gets absorbed into our blood stream and organs, so Leah and Sarah became incredibly passionate about doing the research and understanding the ingredients our bodies consume daily. Sarah and Leah wished there was a beauty brand that focused on organic, nourishing ingredients but also stood for something bigger than beauty! Or I wake up around 6:30 with our 3-year old and 5 year old.

In 2015, Sarah was diagnosed with Stage 3 Triple Negative Breast Cancer, at 36 years old and 32 weeks pregnant. When something like this happens, it turns your world upside down

IMMU-132-01 Phase 1/2 clinical trial using Immunomedics’ sacituzumab govitecan drug has revealed that this drug increases survival time and shrinks tumor in metastatic triple negative breast patients. In this clinical trial, 108 metastatic breast cancer patients who had been previously treated with other medications received the sacituzumab govitecan drug